GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection - Top-Institutions - MDSpire

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection

  • By

  • Mengting Yang

  • Zhigang Liang

  • June 23, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University College London (UCL) Queen Square Institute of Neurology and National Hospital for Neurology & Neurosurgery
    University College London (UCL) Queen Square Institute of Neurology and National Hospital for Neurology & Neurosurgery

    London, United Kingdom

    Key Differentiators

    • Neurology

  • #2

    Imperial College London & Imperial College Healthcare NHS Trust
    Imperial College London & Imperial College Healthcare NHS Trust

    London, United Kingdom

    Key Differentiators

    • Neurology

Original Source(s)

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection

  • by Mengting Yang, Zhigang Liang

  • June 23, 2026

Related Content

Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology

Activity-dependent adaptive deep brain stimulation improves gait in Parkinson’s disease

Sequential ¹⁸F‑AV45/¹⁸F‑AV1451 dual‑tracer brain PET imaging in Alzheimer's disease: amyloid‑tau deposition, diagnostic performance, cognitive associations, and modulation by APOE ε4